Navigation Links
VersaNail

ProductsVersaNail
Company DePuy Orthopaedics, Inc.
Item VersaNail
Features 
  • Implant Versatility through design- Including options for Lateral-Medial or Posterior-Anterior distal screw orientation, three holes for anatomical distal locking, both a proximal locking static hole and dynamization slot, and a wide range of end cap and implant options
  • Instrumentation Versatility - Color coded instrumentation for ease of use, rotating targeting device enables 90 positions around the foot, an adjustable, stable proximal targeting carriage for nail length settings, intra-operative controlled proximal dynamization with the benefit of axial compression capabilities
  • Description The VersaNail System is a complete system of surgical instruments and implants for surgeons to use with TTC fusion surgery. The system was designed in consultation with orthopaedic specialists and integrates clinical research and engineering with advanced materials, techniques and anatomical design. Because every patient is different, and because the anatomy of the foot and ankle are very complex, the VersaNail System provides a range of implant sizes and instrument versatility, giving surgeons more choices for their patients.
    Info DePuy Orthopaedics, Inc.
    Customer Service: (800) 366-8143
    Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

    Related medicine products :

    1. VersaNail™
    ... 4F, 5F, and 6F ... is ideal for coronary ... state-of-the-art technology and proprietary ... better responsiveness, optimal torque, ...
    The advanced center-of-the-arc system allows an infinite choice of trajectories. The system's lightweight durable frame provides accuracy, simplicity, patient mobility and accessibility....
    The Cygnus-PFS Image-Guided Surgery System is the world's first portable and affordable image-guided surgery system....
    Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
    Medicine Products:
    (Date:4/21/2017)... ... April 21, 2017 , ... Contrary to popular ... violence is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright and his ... in violence in the United States. The study, Trends in Fighting and ...
    (Date:4/21/2017)... PA (PRWEB) , ... April 21, 2017 , ... ... firm in Allegheny County that offers services to communities throughout the greater Pittsburgh ... in a charity drive to provide adaptive bicycles for differently-abled children. , Variety ...
    (Date:4/21/2017)... ... April 21, 2017 , ... ... named Agency of Record (AOR) for Theravent, Inc. , the makers of ... parent company, Foundation Consumer Healthcare, is now working to expand distribution in anticipation ...
    (Date:4/21/2017)... ... April 21, 2017 , ... Alive for Wellness is ... overcome their mental health struggles. The Alive team uses advanced behavioral sciences treatment ... in dealing with a mental health struggle is based on 10 modalities of ...
    (Date:4/21/2017)... ... April 21, 2017 , ... ... practices, is seeking candidates to serve on its Accreditation and Standards Committees ... “RadSite’s ultimate mission is improving image quality and reducing patient radiation dose,” ...
    Breaking Medicine News(10 mins):
    (Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
    (Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
    (Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
    Breaking Medicine Technology: